Scholarlink

<p>A reversed phase HPLC method with UV detection was designed for the first time for the simultaneous estimation of meloxicam and esomeprazole in their combined tablet dosage forms. Full factorial design was used for rapid optimization of the proposed method. Chromatographic separation was reached using isocratic elution on C18 column. The mobile phase was a mixture of methanol: acetonitrile: 0.05&#xa0;M potassium dihydrogen phosphate buffer at pH 5, adjusted using phosphoric acid and/or NaOH when needed. The flow rate was 1 mL/min and the injection volume was 20 µL. The detection wavelength was 230&#xa0;nm. The working ranges of the method were 5.0-100.0 and 10.0–100.0&#xa0;µg/mL, LOD values were 0.8 and 1.8&#xa0;µg/mL and LOQ values were 2.6 and 5.5&#xa0;µg/mL for meloxicam and esomeprazole, respectively. The proposed method was successfully applied to their combined tablet dosage forms with acceptable % recoveries (100.4 − 100.7%) obtained. Four methods were used to evaluate the greenness of the proposed method, suggesting the acceptability of the greenness of the proposed method. </p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Deduction of full factorial design of HPLC technique for the simultaneous analysis of meloxicam and esomeprazole in their laboratory prepared tablets

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月15日

查看全文
  • Hesham Sameh Ramadan,
  • Fathalla Belal,
  • Aya Roshdy,
  • Mohamed M. Salim

摘要

A reversed phase HPLC method with UV detection was designed for the first time for the simultaneous estimation of meloxicam and esomeprazole in their combined tablet dosage forms. Full factorial design was used for rapid optimization of the proposed method. Chromatographic separation was reached using isocratic elution on C18 column. The mobile phase was a mixture of methanol: acetonitrile: 0.05 M potassium dihydrogen phosphate buffer at pH 5, adjusted using phosphoric acid and/or NaOH when needed. The flow rate was 1 mL/min and the injection volume was 20 µL. The detection wavelength was 230 nm. The working ranges of the method were 5.0-100.0 and 10.0–100.0 µg/mL, LOD values were 0.8 and 1.8 µg/mL and LOQ values were 2.6 and 5.5 µg/mL for meloxicam and esomeprazole, respectively. The proposed method was successfully applied to their combined tablet dosage forms with acceptable % recoveries (100.4 − 100.7%) obtained. Four methods were used to evaluate the greenness of the proposed method, suggesting the acceptability of the greenness of the proposed method.